CVS · 8-K · 20261104PR000107
Cash Flow and Liquidity
CVS HEALTH Corp · 2026-11-04 · Importance 63 · Surprise 64 · From source text
Cash flow from operations for the first nine months of 2026 was $15.318 billion, up from $7.249 billion in the comparable 2025 period. Cash and cash equivalents at September 30, 2026 were $11.738 billion, compared with $8.453 billion at December 31, 2025; cash, cash equivalents, and restricted cash totaled $11.948 billion at period-end. The company used $5.545 billion in investing activities and $6.537 billion in financing activities during the nine months.
Key facts
- CVS Health generated $15.318 billion of net cash provided by operating activities in the nine months ended September 30, 2026, compared with $7.249 billion in the prior-year period. source
- CVS Health had $11.738 billion of cash and cash equivalents as of September 30, 2026, compared with $8.453 billion as of December 31, 2025. source
- CVS Health generated $15.3 billion of cash flow from operations year to date through September 30, 2026. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| cash | positive | realized | +3.2% | CVS Health generated $15.318 billion of net cash provided by operating activities in the nine months ended September 30, 2026, compared… |
| cash | positive | realized | +1.3% | CVS Health had $11.738 billion of cash and cash equivalents as of September 30, 2026, compared with $8.453 billion as of December 31, 2025. |